Crossmark

Downregulation of SRSF3 by antisense oligonucleotides sensitizes oral squamous cell carcinoma and breast cancer cells to paclitaxel treatment

Published Online: 2019-09-12

Published Print: 2019-11

Authors

Sun, Yanan

Yan, Lingyan

Guo, Jihua

Shao, Jun

Jia, Rong https://orcid.org/0000-0001-6960-6199
Funding

Funding for this research was provided by:

National Science Foundation of China (81470741)

National Science Foundation of China (81271143)

National Science Foundation of China (81571024)

Health Commission of Hubei Province scientific research project (WJ2019Z014)

Hubei Provincial Natural Science Foundation of China (2019CFB643)
License Information

Text and Data Mining valid from 2019-09-12

Version of Record valid from 2019-09-12
More Information

Article History

Received: 21 April 2019

Accepted: 28 August 2019

First Online: 12 September 2019

Compliance with ethical standards

:

: The authors declare that they have no conflicts of interest.

: Informed consents were obtained from all participants. All experimental protocols were approved by the Ethics Committee at Hubei Cancer Hospital.

Document is current